Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1305 studies found for:    "Uterine Neoplasms"
Show Display Options
Rank Status Study
1 Unknown  Epidemiology of Uterine Cancer in Taiwan
Condition: Uterine Cancers
Intervention: Other: Histologic types
2 Terminated A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
Condition: Uterine Cancer
Intervention: Drug: Celecoxib
3 Recruiting MRI and Metabolomics Biomarkers for Uterine Malignancy
Condition: Uterine Neoplasms
Intervention:
4 Recruiting Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix
Conditions: Uterine Cancer;   Cervical Cancer
Intervention: Radiation: Proton radiation therapy
5 Completed
Has Results
Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
Condition: Mixed Mullerian Tumors of the Uterus
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Radiation: Radiation
6 Terminated
Has Results
A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus
Condition: Uterine Cancer
Intervention: Drug: Paclitaxel and carboplatin combination
7 Terminated Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy
Condition: Uterine Neoplasms
Interventions: Drug: Carboplatin;   Drug: Cisplatin;   Drug: Paclitaxel
8 Completed
Has Results
A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer
Condition: Uterine Cancer
Intervention: Drug: Paclitaxel ,Carboplatin , Megesterol Acetate
9 Recruiting The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection
Condition: Uterine Cancer
Interventions: Drug: Dexmedetomidine group;   Drug: Control group
10 Terminated Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer
Condition: Uterine Neoplasms
Interventions: Drug: Oxaliplatin;   Drug: 5-FluoroUracil;   Drug: Folinic acid
11 Completed Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
Conditions: Ovarian Neoplasms;   Uterine Neoplasms
Intervention: Drug: Topotecan and Taxotere
12 Unknown  Sentinel Node Biopsy in Endometrial Cancer
Conditions: Uterine Neoplasms;   Sentinel Lymph Node Biopsy
Intervention: Procedure: Sentinel Lymph Node Biopsy
13 Withdrawn High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection
Condition: Uterine Cancer
Interventions: Procedure: High-Resolution Microendoscopy Imaging;   Drug: Proflavine
14 Active, not recruiting Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Intervention: Drug: Letrozole
15 Completed Uterine Papillary Serous Cancer (UPSC) Trial
Condition: Uterine Cancer
Intervention: Drug: Paclitaxel, Carboplatin
16 Completed Self-Hypnotic Relaxation Therapy During Invasive Procedures
Conditions: Uterine Neoplasms;   Leiomyoma
Intervention: Behavioral: Self-hypnotic relaxation
17 Completed A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus
Condition: Uterine Cancer
Interventions: Drug: Ifosfamide;   Procedure: Radiation Therapy
18 Completed
Has Results
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Intervention: Drug: gemcitabine, docetaxel, doxorubicin
19 Completed Pre-Clinical Models in Gynecological Tumors A Tissue Repository
Conditions: Endometrial Neoplasms;   Uterine Neoplasms
Intervention:
20 Completed Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
Condition: Uterine Cancer
Interventions: Drug: Imatinib Mesylate;   Drug: Paclitaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.